 | • レポートコード：GIR-2104Z11887 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、腎臓用バイオマーカーのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。腎臓用バイオマーカーの種類別市場規模（酵素免疫測定法（ELISA）、酵素アッセイ、比濁法イムノアッセイ、その他）、用途別市場規模（診断・病気進行監視、研究、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・腎臓用バイオマーカーの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Abbott Diagnostics、F. Hoffmann-La Roche、Beckman Coulter、Siemens Healthcare Diagnostics、Thermo Fisher Scientific、Astute Medical、BioMerieux SA、Randox Laboratories ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：酵素免疫測定法（ELISA）、酵素アッセイ、比濁法イムノアッセイ、その他 ・用途別分析2016年-2026年：診断・病気進行監視、研究、その他 ・腎臓用バイオマーカーの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・腎臓用バイオマーカーのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・腎臓用バイオマーカーのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・腎臓用バイオマーカーの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・腎臓用バイオマーカーの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Renal Biomarkers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Renal Biomarkers size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Renal Biomarkers market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Renal Biomarkers market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Enzyme Linked Immunosorbent Assay (ELISA)
Enzymatic Assay
Turbidimetric Immunoassay
Others
Market segment by Application, can be divided into
Diagnosis and Disease Progression Monitoring
Research
Others
Market segment by players, this report covers
Abbott Diagnostics
F. Hoffmann-La Roche
Beckman Coulter
Siemens Healthcare Diagnostics
Thermo Fisher Scientific
Astute Medical
BioMerieux SA
Randox Laboratories
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Renal Biomarkers
1.2 Classification of Renal Biomarkers by Type
1.2.1 Overview: Global Renal Biomarkers Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Renal Biomarkers Revenue Market Share by Type in 2020
1.2.3 Enzyme Linked Immunosorbent Assay (ELISA)
1.2.4 Enzymatic Assay
1.2.5 Turbidimetric Immunoassay
1.2.6 Others
1.3 Global Renal Biomarkers Market by Application
1.3.1 Overview: Global Renal Biomarkers Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Diagnosis and Disease Progression Monitoring
1.3.3 Research
1.3.4 Others
1.4 Global Renal Biomarkers Market Size & Forecast
1.5 Global Renal Biomarkers Market Size and Forecast by Region
1.5.1 Global Renal Biomarkers Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Renal Biomarkers Market Size by Region, (2016-2021)
1.5.3 North America Renal Biomarkers Market Size and Prospect (2016-2026)
1.5.4 Europe Renal Biomarkers Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Renal Biomarkers Market Size and Prospect (2016-2026)
1.5.6 South America Renal Biomarkers Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Renal Biomarkers Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Renal Biomarkers Market Drivers
1.6.2 Renal Biomarkers Market Restraints
1.6.3 Renal Biomarkers Trends Analysis
2 Company Profiles
2.1 Abbott Diagnostics
2.1.1 Abbott Diagnostics Details
2.1.2 Abbott Diagnostics Major Business
2.1.3 Abbott Diagnostics Renal Biomarkers Product and Solutions
2.1.4 Abbott Diagnostics Renal Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abbott Diagnostics Recent Developments and Future Plans
2.2 F. Hoffmann-La Roche
2.2.1 F. Hoffmann-La Roche Details
2.2.2 F. Hoffmann-La Roche Major Business
2.2.3 F. Hoffmann-La Roche Renal Biomarkers Product and Solutions
2.2.4 F. Hoffmann-La Roche Renal Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.3 Beckman Coulter
2.3.1 Beckman Coulter Details
2.3.2 Beckman Coulter Major Business
2.3.3 Beckman Coulter Renal Biomarkers Product and Solutions
2.3.4 Beckman Coulter Renal Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Beckman Coulter Recent Developments and Future Plans
2.4 Siemens Healthcare Diagnostics
2.4.1 Siemens Healthcare Diagnostics Details
2.4.2 Siemens Healthcare Diagnostics Major Business
2.4.3 Siemens Healthcare Diagnostics Renal Biomarkers Product and Solutions
2.4.4 Siemens Healthcare Diagnostics Renal Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Siemens Healthcare Diagnostics Recent Developments and Future Plans
2.5 Thermo Fisher Scientific
2.5.1 Thermo Fisher Scientific Details
2.5.2 Thermo Fisher Scientific Major Business
2.5.3 Thermo Fisher Scientific Renal Biomarkers Product and Solutions
2.5.4 Thermo Fisher Scientific Renal Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.6 Astute Medical
2.6.1 Astute Medical Details
2.6.2 Astute Medical Major Business
2.6.3 Astute Medical Renal Biomarkers Product and Solutions
2.6.4 Astute Medical Renal Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Astute Medical Recent Developments and Future Plans
2.7 BioMerieux SA
2.7.1 BioMerieux SA Details
2.7.2 BioMerieux SA Major Business
2.7.3 BioMerieux SA Renal Biomarkers Product and Solutions
2.7.4 BioMerieux SA Renal Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 BioMerieux SA Recent Developments and Future Plans
2.8 Randox Laboratories
2.8.1 Randox Laboratories Details
2.8.2 Randox Laboratories Major Business
2.8.3 Randox Laboratories Renal Biomarkers Product and Solutions
2.8.4 Randox Laboratories Renal Biomarkers Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Randox Laboratories Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Renal Biomarkers Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Renal Biomarkers Players Market Share
3.2.2 Top 10 Renal Biomarkers Players Market Share
3.2.3 Market Competition Trend
3.3 Renal Biomarkers Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Renal Biomarkers Revenue and Market Share by Type (2016-2021)
4.2 Global Renal Biomarkers Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Renal Biomarkers Revenue Market Share by Application (2016-2021)
5.2 Renal Biomarkers Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Renal Biomarkers Revenue by Type (2016-2026)
6.2 North America Renal Biomarkers Revenue by Application (2016-2026)
6.3 North America Renal Biomarkers Market Size by Country
6.3.1 North America Renal Biomarkers Revenue by Country (2016-2026)
6.3.2 United States Renal Biomarkers Market Size and Forecast (2016-2026)
6.3.3 Canada Renal Biomarkers Market Size and Forecast (2016-2026)
6.3.4 Mexico Renal Biomarkers Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Renal Biomarkers Revenue by Type (2016-2026)
7.2 Europe Renal Biomarkers Revenue by Application (2016-2026)
7.3 Europe Renal Biomarkers Market Size by Country
7.3.1 Europe Renal Biomarkers Revenue by Country (2016-2026)
7.3.2 Germany Renal Biomarkers Market Size and Forecast (2016-2026)
7.3.3 France Renal Biomarkers Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Renal Biomarkers Market Size and Forecast (2016-2026)
7.3.5 Russia Renal Biomarkers Market Size and Forecast (2016-2026)
7.3.6 Italy Renal Biomarkers Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Renal Biomarkers Revenue by Type (2016-2026)
8.2 Asia-Pacific Renal Biomarkers Revenue by Application (2016-2026)
8.3 Asia-Pacific Renal Biomarkers Market Size by Region
8.3.1 Asia-Pacific Renal Biomarkers Revenue by Region (2016-2026)
8.3.2 China Renal Biomarkers Market Size and Forecast (2016-2026)
8.3.3 Japan Renal Biomarkers Market Size and Forecast (2016-2026)
8.3.4 South Korea Renal Biomarkers Market Size and Forecast (2016-2026)
8.3.5 India Renal Biomarkers Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Renal Biomarkers Market Size and Forecast (2016-2026)
8.3.7 Australia Renal Biomarkers Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Renal Biomarkers Revenue by Type (2016-2026)
9.2 South America Renal Biomarkers Revenue by Application (2016-2026)
9.3 South America Renal Biomarkers Market Size by Country
9.3.1 South America Renal Biomarkers Revenue by Country (2016-2026)
9.3.2 Brazil Renal Biomarkers Market Size and Forecast (2016-2026)
9.3.3 Argentina Renal Biomarkers Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Renal Biomarkers Revenue by Type (2016-2026)
10.2 Middle East & Africa Renal Biomarkers Revenue by Application (2016-2026)
10.3 Middle East & Africa Renal Biomarkers Market Size by Country
10.3.1 Middle East & Africa Renal Biomarkers Revenue by Country (2016-2026)
10.3.2 Turkey Renal Biomarkers Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Renal Biomarkers Market Size and Forecast (2016-2026)
10.3.4 UAE Renal Biomarkers Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Renal Biomarkers Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Renal Biomarkers Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Renal Biomarkers Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Renal Biomarkers Revenue (USD Million) by Region (2016-2021)
Table 5. Global Renal Biomarkers Revenue Market Share by Region (2021-2026)
Table 6. Abbott Diagnostics Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Diagnostics Major Business
Table 8. Abbott Diagnostics Renal Biomarkers Product and Solutions
Table 9. Abbott Diagnostics Renal Biomarkers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. F. Hoffmann-La Roche Corporate Information, Head Office, and Major Competitors
Table 11. F. Hoffmann-La Roche Major Business
Table 12. F. Hoffmann-La Roche Renal Biomarkers Product and Solutions
Table 13. F. Hoffmann-La Roche Renal Biomarkers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Beckman Coulter Corporate Information, Head Office, and Major Competitors
Table 15. Beckman Coulter Major Business
Table 16. Beckman Coulter Renal Biomarkers Product and Solutions
Table 17. Beckman Coulter Renal Biomarkers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Siemens Healthcare Diagnostics Corporate Information, Head Office, and Major Competitors
Table 19. Siemens Healthcare Diagnostics Major Business
Table 20. Siemens Healthcare Diagnostics Renal Biomarkers Product and Solutions
Table 21. Siemens Healthcare Diagnostics Renal Biomarkers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 23. Thermo Fisher Scientific Major Business
Table 24. Thermo Fisher Scientific Renal Biomarkers Product and Solutions
Table 25. Thermo Fisher Scientific Renal Biomarkers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Astute Medical Corporate Information, Head Office, and Major Competitors
Table 27. Astute Medical Major Business
Table 28. Astute Medical Renal Biomarkers Product and Solutions
Table 29. Astute Medical Renal Biomarkers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. BioMerieux SA Corporate Information, Head Office, and Major Competitors
Table 31. BioMerieux SA Major Business
Table 32. BioMerieux SA Renal Biomarkers Product and Solutions
Table 33. BioMerieux SA Renal Biomarkers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Randox Laboratories Corporate Information, Head Office, and Major Competitors
Table 35. Randox Laboratories Major Business
Table 36. Randox Laboratories Renal Biomarkers Product and Solutions
Table 37. Randox Laboratories Renal Biomarkers Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Global Renal Biomarkers Revenue (USD Million) by Players (2019-2021)
Table 39. Global Renal Biomarkers Revenue Share by Players (2019-2021)
Table 40. Breakdown of Renal Biomarkers by Company Type (Tier 1, Tier 2 and Tier 3)
Table 41. Renal Biomarkers Players Head Office, Products and Services Provided
Table 42. Renal Biomarkers Mergers & Acquisitions in the Past Five Years
Table 43. Renal Biomarkers New Entrants and Expansion Plans
Table 44. Global Renal Biomarkers Revenue (USD Million) by Type (2016-2021)
Table 45. Global Renal Biomarkers Revenue Share by Type (2016-2021)
Table 46. Global Renal Biomarkers Revenue Forecast by Type (2021-2026)
Table 47. Global Renal Biomarkers Revenue by Application (2016-2021)
Table 48. Global Renal Biomarkers Revenue Forecast by Application (2021-2026)
Table 49. North America Renal Biomarkers Revenue by Type (2016-2021) & (USD Million)
Table 50. North America Renal Biomarkers Revenue by Type (2021-2026) & (USD Million)
Table 51. North America Renal Biomarkers Revenue by Application (2016-2021) & (USD Million)
Table 52. North America Renal Biomarkers Revenue by Application (2021-2026) & (USD Million)
Table 53. North America Renal Biomarkers Revenue by Country (2016-2021) & (USD Million)
Table 54. North America Renal Biomarkers Revenue by Country (2021-2026) & (USD Million)
Table 55. Europe Renal Biomarkers Revenue by Type (2016-2021) & (USD Million)
Table 56. Europe Renal Biomarkers Revenue by Type (2021-2026) & (USD Million)
Table 57. Europe Renal Biomarkers Revenue by Application (2016-2021) & (USD Million)
Table 58. Europe Renal Biomarkers Revenue by Application (2021-2026) & (USD Million)
Table 59. Europe Renal Biomarkers Revenue by Country (2016-2021) & (USD Million)
Table 60. Europe Renal Biomarkers Revenue by Country (2021-2026) & (USD Million)
Table 61. Asia-Pacific Renal Biomarkers Revenue by Type (2016-2021) & (USD Million)
Table 62. Asia-Pacific Renal Biomarkers Revenue by Type (2021-2026) & (USD Million)
Table 63. Asia-Pacific Renal Biomarkers Revenue by Application (2016-2021) & (USD Million)
Table 64. Asia-Pacific Renal Biomarkers Revenue by Application (2021-2026) & (USD Million)
Table 65. Asia-Pacific Renal Biomarkers Revenue by Region (2016-2021) & (USD Million)
Table 66. Asia-Pacific Renal Biomarkers Revenue by Region (2021-2026) & (USD Million)
Table 67. South America Renal Biomarkers Revenue by Type (2016-2021) & (USD Million)
Table 68. South America Renal Biomarkers Revenue by Type (2021-2026) & (USD Million)
Table 69. South America Renal Biomarkers Revenue by Application (2016-2021) & (USD Million)
Table 70. South America Renal Biomarkers Revenue by Application (2021-2026) & (USD Million)
Table 71. South America Renal Biomarkers Revenue by Country (2016-2021) & (USD Million)
Table 72. South America Renal Biomarkers Revenue by Country (2021-2026) & (USD Million)
Table 73. Middle East & Africa Renal Biomarkers Revenue by Type (2016-2021) & (USD Million)
Table 74. Middle East & Africa Renal Biomarkers Revenue by Type (2021-2026) & (USD Million)
Table 75. Middle East & Africa Renal Biomarkers Revenue by Application (2016-2021) & (USD Million)
Table 76. Middle East & Africa Renal Biomarkers Revenue by Application (2021-2026) & (USD Million)
Table 77. Middle East & Africa Renal Biomarkers Revenue by Country (2016-2021) & (USD Million)
Table 78. Middle East & Africa Renal Biomarkers Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Renal Biomarkers Picture
Figure 2. Global Renal Biomarkers Revenue Market Share by Type in 2020
Figure 3. Enzyme Linked Immunosorbent Assay (ELISA)
Figure 4. Enzymatic Assay
Figure 5. Turbidimetric Immunoassay
Figure 6. Others
Figure 7. Renal Biomarkers Revenue Market Share by Application in 2020
Figure 8. Diagnosis and Disease Progression Monitoring Picture
Figure 9. Research Picture
Figure 10. Others Picture
Figure 11. Global Renal Biomarkers Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Renal Biomarkers Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Renal Biomarkers Revenue Market Share by Region (2016-2026)
Figure 14. Global Renal Biomarkers Revenue Market Share by Region in 2020
Figure 15. North America Renal Biomarkers Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Renal Biomarkers Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Renal Biomarkers Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Renal Biomarkers Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Renal Biomarkers Market Drivers
Figure 20. Renal Biomarkers Market Restraints
Figure 21. Renal Biomarkers Market Trends
Figure 22. Abbott Diagnostics Recent Developments and Future Plans
Figure 23. F. Hoffmann-La Roche Recent Developments and Future Plans
Figure 24. Beckman Coulter Recent Developments and Future Plans
Figure 25. Siemens Healthcare Diagnostics Recent Developments and Future Plans
Figure 26. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 27. Astute Medical Recent Developments and Future Plans
Figure 28. BioMerieux SA Recent Developments and Future Plans
Figure 29. Randox Laboratories Recent Developments and Future Plans
Figure 31. Global Renal Biomarkers Revenue Share by Players in 2020
Figure 32. Renal Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 33. Global Top 3 Players Renal Biomarkers Revenue Market Share in 2020
Figure 34. Global Top 10 Players Renal Biomarkers Revenue Market Share in 2020
Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 36. Global Renal Biomarkers Revenue Share by Type in 2020
Figure 37. Global Renal Biomarkers Market Share Forecast by Type (2021-2026)
Figure 38. Global Renal Biomarkers Revenue Share by Application in 2020
Figure 39. Global Renal Biomarkers Market Share Forecast by Application (2021-2026)
Figure 40. North America Renal Biomarkers Sales Market Share by Type (2016-2026)
Figure 41. North America Renal Biomarkers Sales Market Share by Application (2016-2026)
Figure 42. North America Renal Biomarkers Revenue Market Share by Country (2016-2026)
Figure 43. United States Renal Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Renal Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Renal Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Renal Biomarkers Sales Market Share by Type (2016-2026)
Figure 47. Europe Renal Biomarkers Sales Market Share by Application (2016-2026)
Figure 48. Europe Renal Biomarkers Revenue Market Share by Country (2016-2026)
Figure 49. Germany Renal Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Renal Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Renal Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Renal Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Renal Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Renal Biomarkers Sales Market Share by Type (2016-2026)
Figure 55. Asia-Pacific Renal Biomarkers Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Renal Biomarkers Revenue Market Share by Region (2016-2026)
Figure 57. China Renal Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Renal Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. South Korea Renal Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Renal Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Renal Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Renal Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Renal Biomarkers Sales Market Share by Type (2016-2026)
Figure 64. South America Renal Biomarkers Sales Market Share by Application (2016-2026)
Figure 65. South America Renal Biomarkers Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Renal Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Renal Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East and Africa Renal Biomarkers Sales Market Share by Type (2016-2026)
Figure 69. Middle East and Africa Renal Biomarkers Sales Market Share by Application (2016-2026)
Figure 70. Middle East and Africa Renal Biomarkers Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Renal Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Saudi Arabia Renal Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. UAE Renal Biomarkers Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Methodology
Figure 75. Research Process and Data Source
世界の急性腎不全治療市場規模・現状・予測（2021年-2027年） Acute renal failure is a sudden loss of kidney’s ability to eliminate excess fluids, salts and metabolic waste from the body. It leads to accumulation of metabolic waste and electrolytes in the body which can be life-threatening. Kidney eliminates creatinine (Metabolic waste) from the body. Acute re…- 世界の急性腎不全治療市場規模・現状・予測（2021年-2027年） Acute renal failure is a sudden loss of kidney’s ability to eliminate excess fluids, salts and metabolic waste from the body. It leads to accumulation of metabolic waste and electrolytes in the body which can be life-threatening. Kidney eliminates creatinine (Metabolic waste) from the body. Acute re…
- 世界のゲノミクスバイオマーカー市場規模・現状・予測（2021年-2027年） A measurable DNA and/or RNA characteristic is an indicator of normal biologic processes, pathogenic processes, and/or response to a therapeutic or other interventions. A genomic biomarker can be used for measuring the expression, function, and regulation of a gene. These biomarkers have characterist…
- 世界の予測バイオマーカー市場規模・現状・予測（2021年-2027年） Predictive biomarkers help to optimize therapy decisions, as they provide information on the likelihood of response to a given chemotherapeutic. The predictive biomarkers market is expected to register a fast growth over the forecast period owing to the increase in the prevalence rate of cancer. Mar…
- 世界の持続的腎代替療法（CRRT）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Continuous Renal Replacement Therapy Market The global Continuous Renal Replacement Therapy market size is projected to reach US$ 999.1 million by 2026, from US$ 755.5 million in 2019, at a CAGR of 4.0% during 2021-2026. With industry-standard accuracy in analysi…